Vanda Pharmaceuticals
VNDA
#7396
Rank
NZ$0.74 B
Marketcap
NZ$12.68
Share price
5.53%
Change (1 day)
59.29%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -NZ$0.21 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.21 Billion. In 2024 the company made an earning of -NZ$67.59 Million a decrease over its 2023 earnings that were of -NZ$23.2 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.21 Billion207.38%
2024 -NZ$67.59 Million191.43%
2023 -NZ$23.2 Million-320.45%
2022 NZ$10.52 M-84.99%
2021 NZ$70.09 M54.8%
2020 NZ$45.27 M19.42%
2019 NZ$37.91 M4.93%
2018 NZ$36.13 M-228.6%
2017 -NZ$28.1 Million-8.98%
2016 -NZ$30.88 Million-53.79%
2015 -NZ$66.8 Million-30.18%
2014 -NZ$95.68 Million173.08%
2013 -NZ$35.04 Million-25.33%
2012 -NZ$46.92 Million163.61%
2011 -NZ$17.8 Million-221.15%
2010 NZ$14.69 M-124.53%
2009 -NZ$59.9 Million-29.44%
2008 -NZ$84.89 Million-36.2%
2007 -NZ$0.14 Billion21.81%
2006 -NZ$0.11 Billion170.55%
2005 -NZ$40.38 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$53.85 B-26,852.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.29 B-13,658.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$19.70 B-9,887.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$37.40 B-18,683.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$38.38 B-19,167.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.35 B-6,733.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-NZ$4.67 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA